Powered and implemented by Interactive Data Managed Solutions. The settlement of this case removes a cloud of uncertainty and ensures that current and future stakeholders will enjoy the benefits of the ongoing transformation of Bausch Health.". Valeant Pharmaceuticals International, Inc. (VRX.TO) does not currently pay a dividend. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. Below is the stock price history for Valeant Pharmaceuticals Intl I VRX. Share . Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. This Stock Is a Buy. S&P. Compare. Valeant Pharmaceuticals International, Inc. operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. Please log in to your account or sign up in order to add this asset to your watchlist. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell My Info | Ad Choices Below is the stock price history for Valeant Pharmaceuticals Intl I VRX. //-->, » More Valeant Pharmaceuticals Intl I Stock Price History. And with over $23 billion in long-term debt compared with only $825 million in cash and $3.5 billion in projected 2019 EBITDA, Bausch is certainly that. You may vote once every thirty days. /* StockPriceToday468 */ With all these lawsuits on the table, it may look like Bausch Health is having a hard time progressing beyond its Valeant days. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Trading at upwards of $200 per share in 2015, Valeant Pharmaceuticals was once a Wall Street darling.